Fundraising FoxIgenica Biotherapeutics
Burlingame, US · Delaware corporation · 3 known investors
Find your way into Igenica Biotherapeutics
Sign up to see every warm intro you have to Igenica Biotherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Igenica Biotherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JC
John CelebiExecutive
MH
Mary Haak-FrendschoExecutive
Board
JD
CG
DG
RS
Robert SchreiberBoard director
MG
Mark GoldsmithBoard director
GF
Gwen FyfeBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$15.6M disclosed across 4 rounds · 2014–2015
▶$2.3MraisedOct 2015 · 10 investors · PharmaceuticalsRule 506(b)
▶$2.3MraisedOct 2015 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mark GoldsmithDirector
- John CelebiExecutive Officer
- John DiekmanDirector
- Robert SchreiberDirector
- David GoeddelDirector
- Gwen FyfeDirector
- Offering amount
- $5M
- Amount sold
- $2.3M
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedJun 2015 · 8 investors · PharmaceuticalsRule 506(b)
▶$1.2MraisedJun 2015 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mark GoldsmithDirector
- David GoeddelDirector
- Gwen FyfeDirector
- Robert SchreiberDirector
- John CelebiExecutive Officer
- John DiekmanDirector
- Offering amount
- $4M
- Amount sold
- $1.2M
- First sale
- May 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.1MraisedJan 2015 · 10 investors · PharmaceuticalsRule 506(b)
▶$5.1MraisedJan 2015 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert SchreiberDirector
- John CelebiExecutive Officer
- John DiekmanDirector
- Mark GoldsmithDirector
- Carl GordonDirector
- David GoeddelDirector
- Gwen FyfeDirector
- Offering amount
- $6.3M
- Amount sold
- $5.1M
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedFeb 2014 · 7 investors · PharmaceuticalsRule 506(b)
▶$7MraisedFeb 2014 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert SchreiberDirector
- Carl GordonDirector
- John CelebiExecutive Officer
- David GoeddelDirector
- Mark GoldsmithDirector
- John DiekmanDirector
- Mary Haak-FrendschoExecutive Officer, Director
- Gwen A. FyfeDirector
- Offering amount
- $14.1M
- Amount sold
- $7M
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Igenica Biotherapeutics's investors?
- Igenica Biotherapeutics's investors include 5AM Ventures, OrbiMed, The Column Group.
- How much funding has Igenica Biotherapeutics raised?
- Igenica Biotherapeutics has disclosed $15.6M raised across 4 rounds.
- Where is Igenica Biotherapeutics headquartered?
- Igenica Biotherapeutics is headquartered in Burlingame, US.